Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

BACKGROUND AND PURPOSE: Concurrent chemoradiation (cCRT) and durvalumab is standard therapy for patients with unresectable stage III non-small-cell lung cancers (NSCLC). Data is limited on outcomes with this regimen outside of clinical trials. Local-regional control rates remain undefined. MATERIALS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiother Oncol
Main Authors: Offin, Michael, Shaverdian, Narek, Rimner, Andreas, Lobaugh, Stephanie, Shepherd, Annemarie F., Simone, Charles B., Gelblum, Daphna Y., Wu, Abraham J., Lee, Nancy, Kris, Mark G., Rudin, Charles M., Zhang, Zhigang, Hellmann, Matthew D., Chaft, Jamie E., Gomez, Daniel R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239428/
https://ncbi.nlm.nih.gov/pubmed/32361014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2020.04.047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados